What is Medtronic's stock-based comp?

Medtronic (MDT) reported stock-based comp of $95M in Q1 2026.

How has Medtronic's stock-based comp changed year-over-year?

Medtronic's stock-based comp increased by 6.7% year-over-year, from $89M to $95M.

What is the long-term trend for Medtronic's stock-based comp?

Over 4 years (2022 to 2026), Medtronic's stock-based comp has grown at a 6.2% compound annual growth rate (CAGR), from $359M to $457M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Medtronic MDT Stock-Based Comp

Stock-Based Comp at other companies

AbbottABT

$317M+9.7%

TFX

TeleflexTFX

$6.74M+1.7%

Johnson & JohnsonJNJ

$300M+4.2%

StrykerSYK

$87M+3.6%

ArtivionAORT

$8.41M+4.6%

CONMEDCNMD

$5.5M-60.3%

Other financials

Income statement

See full

Revenue$9.8B+9.9%

Gross profit$6.4B+10.9%

Operating income$1.9B+30.4%

Net income$1.2B+17.8%

EPS (diluted)$0.97+18.3%

Balance sheet

See full

Cash & equivalents$1.9B-12.1%

Total debt$29.2B-1.6%

Total equity$49.5B+3.0%

Total assets$93.0B+1.5%

Cash flow

See full

Operating cash flow$2.6B+1.8%

CapEx$488.0M+6.3%

Free cash flow$2.1B+0.8%

Valuation

See full

Market cap$100.14B-9.3%

Enterprise value$127.4B-7.6%

P/E20.9×-2.8×

P/S2.8×-0.5×

Profitability

See full

Gross margin65%-0.3pp

Operating margin17.8%0.0pp

Net margin13.2%-0.7pp

FCF margin14.9%-0.5pp

Returns & leverage

See full

Return on equity9.8%+0.4pp

Debt / equity0.6×0.0×

Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medtronic's stock-based comp?: Medtronic (MDT) reported stock-based comp of $95M in Q1 2026.
How has Medtronic's stock-based comp changed year-over-year?: Medtronic's stock-based comp increased by 6.7% year-over-year, from $89M to $95M.
What is the long-term trend for Medtronic's stock-based comp?: Over 4 years (2022 to 2026), Medtronic's stock-based comp has grown at a 6.2% compound annual growth rate (CAGR), from $359M to $457M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.